Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
AMPICILLIN FOR INJECTION, USP FRESENIUS KABI CANADA LTD Actual shortage 250MG Updated Report 2024-04-29 226471
TOBI BGP PHARMA ULC Actual shortage 300MG Updated Report 2024-04-29 192953
VITAMIN C MYLAN PHARMACEUTICALS ULC Actual shortage 500MG Updated Report 2024-04-29 207192
MYLAN-MIRTAZAPINE MYLAN PHARMACEUTICALS ULC Actual shortage 30MG Updated Report 2024-04-29 216953
LUPIN-CEPHALEXIN LUPIN PHARMA CANADA LIMITED Actual shortage 125MG Updated Report 2024-04-29 216518
OCTREOTIDE FOR INJECTABLE SUSPENSION TEVA CANADA LIMITED Actual shortage 10MG Updated Report 2024-04-29 166969
OCTREOTIDE FOR INJECTABLE SUSPENSION TEVA CANADA LIMITED Actual shortage 20MG Updated Report 2024-04-29 166972
OCTREOTIDE FOR INJECTABLE SUSPENSION TEVA CANADA LIMITED Actual shortage 30MG Updated Report 2024-04-29 166975
AURO-CEFPROZIL AURO PHARMA INC Actual shortage 500MG Updated Report 2024-04-29 217630
AURO-AZITHROMYCIN AURO PHARMA INC Actual shortage 200MG Updated Report 2024-04-29 223448

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
PANECTYL SEARCHLIGHT PHARMA INC To be discontinued 5MG New Report 2024-04-26 226355
DELATESTRYL BAUSCH HEALTH, CANADA INC. Discontinued 200MG Updated Report 2024-04-26 221772
STRATTERA ELI LILLY CANADA INC Discontinued 18MG Updated Report 2024-04-24 171480
DULOXETINE SANIS HEALTH INC Reversed 30MG Updated Report 2024-04-23 219618
LIDOCAINE HYDROCHLORIDE INJECTION USP HIKMA CANADA LIMITED Discontinued 10MG Updated Report 2024-04-22 225805